Dr. Christopher Jones
Claim this profileSutter Medical Center Sacramento
About Christopher Jones
Education:
- Obtained an MD (Doctor of Medicine) from the University of California, Davis School of Medicine in 2010.
Experience:
- Completed a Residency in Internal Medicine at Sutter Medical Center Sacramento in 2014.
- Finished a Fellowship in Cardiology at Sutter Medical Center Sacramento in 2017.
Area of expertise
Brain Tumor
Christopher Jones has run 5 trials for Brain Tumor. Some of their research focus areas include:
Prostate Cancer
Christopher Jones has run 4 trials for Prostate Cancer. Some of their research focus areas include:
Affiliated Hospitals
Sutter Medical Center Sacramento
Sutter Cancer Centers Radiation Oncology Services-Roseville
Clinical Trials Christopher Jones is currently running
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to standard chemotherapy with temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. MGMT methylated tumors are more likely to respond to temozolomide chemotherapy. Temozolomide is in a class of medications called alkylating agents. It works by damaging the cell's DNA and may kill tumor cells and slow down or stop tumor growth. Lomustine is a chemotherapy drug and in a class of medications called alkylating agents. It damages the cell's DNA and may kill tumor cells. Radiation therapy uses high energy x-ray photons to kill tumor cells and shrink tumors. Adding lomustine to standard chemotherapy with temozolomide and radiation therapy may shrink or stabilize glioblastoma.
Recruiting
2 awards
Phase 3
4 criteria
Pembrolizumab + Radiation vs Chemotherapy + Radiation
for Head and Neck Cancer
This phase II trial studies the effect of pembrolizumab alone compared to the usual approach (chemotherapy \[cisplatin and carboplatin\] plus radiation therapy) after surgery in treating patients with head and neck squamous cell carcinoma that has come back (recurrent) or patients with a second head and neck cancer that is not from metastasis (primary). Radiation therapy uses high energy radiation or protons to kill tumor cells and shrink tumors. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of cancer cells. Carboplatin is also in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer and may interfere with the ability of tumor cells to grow and spread. Giving pembrolizumab alone after surgery may work better than the usual approach in shrinking recurrent or primary head and neck squamous cell carcinoma.
Recruiting
1 award
Phase 2
31 criteria
More about Christopher Jones
Clinical Trial Related
4 years of experience running clinical trials · Led 26 trials as a Principal Investigator · 10 Active Clinical Trials
Treatments Christopher Jones has experience with
- Cisplatin
- Radiation Therapy
- Bicalutamide
- Intensity-Modulated Radiation Therapy
- Atezolizumab
- Paclitaxel
Breakdown of trials Christopher Jones has run
Brain Tumor
Prostate Cancer
Squamous Cell Carcinoma
Oropharyngeal Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christopher Jones specialize in?
Christopher Jones focuses on Brain Tumor and Prostate Cancer. In particular, much of their work with Brain Tumor has involved IDH positive patients, or patients who are 1p/19q co-deletion positive.
Is Christopher Jones currently recruiting for clinical trials?
Yes, Christopher Jones is currently recruiting for 10 clinical trials in Sacramento California. If you're interested in participating, you should apply.
Are there any treatments that Christopher Jones has studied deeply?
Yes, Christopher Jones has studied treatments such as Cisplatin, Radiation Therapy, Bicalutamide.
What is the best way to schedule an appointment with Christopher Jones?
Apply for one of the trials that Christopher Jones is conducting.
What is the office address of Christopher Jones?
The office of Christopher Jones is located at: Sutter Medical Center Sacramento, Sacramento, California 95816 United States. This is the address for their practice at the Sutter Medical Center Sacramento.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.